Table 1 Clinical and biochemical characteristics of the study patients (N = 14).

No	Age (y)	Gender	Preoperative symptom	Diagnosis	Operation	Hereditary disease	Post operative symptoms	Pre operative serum insulin (μU/ml)	Post operative serum insulin (μU/ml)	Preoperative serum gastrin (pg/ml)	Post operative serum gastrin (pg/ml)	OS (months)	Recurrence	Status
1	36	M	Hypoglycemia	Insulinoma	PP	–	N	149	8	–	–	254	None	Alive
2	51	F	Hypoglycemia	Insulinoma	DP	–	N	51	2	–	–	233	None	Alive
3	70	M	Hypoglycemia	Insulinoma	EN	MEN–I	N	164	6	–	–	119	None	Alive
4	38	M	Hypercalcemia	Insulinoma	DP	MEN-I	N	34	8	–	–	59	Bone, lymph node (Ao)	Dead
5	58	M	Melena	Gastrinoma	PP	–	N	–	–	17,800	39	87	None	Alive
6	48	F	Hypoglycemia	Insulinoma	PP	–	N	272	2	–	–	85	None	Alive
7	43	M	Asymptomatic	Gastrinoma	PP	MEN-I	–	–	–	911	50	80	None	Alive
8	67	F	Hypoglycemia	Insulinoma	EN (Lap)	–	N	44	4	–	–	66	None	Alive
9	18	M	Hypoglycemia	Insulinoma	DP (Lap)	–	N	67	11	–	–	60	None	Alive
10	74	F	Hypoglycemia	Insulinoma	PD	–	N	142	10	–	–	45	None	Alive
11	33	F	Hypoglycemia	Insulinoma	EN (Lap)	–	N	50	4	–	–	31	None	Alive
12	75	M	Hypoglycemia	Insulinoma	DP (Lap)	–	N	39	4	–	–	30	None	Alive
13	58	F	Hypoglycemia	Insulinoma	EN	–	N	10	3	–	–	28	None	Alive
14	70	F	Elevation of HbA1c	Gastrinoma	DP (Lap)	–	–	–	–	994	387	24	None	Alive

Ao aorta, DP distal pancreatectomy, EN enucleation, Lap laparoscopic, MEN-I multiple endocrine neoplasia type 1, N none, OS overall survival, PD pancreaticoduodenectomy, PP partial pancreatectomy.

Quick links

Search